Article info
PDFHow to do it
Diagnosis of amyloid neuropathy
- Correspondence to Professor Mary M Reilly, MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, WC1N 3BG, UK; m.reilly{at}ucl.ac.uk
Citation
Diagnosis of amyloid neuropathy
Publication history
- Accepted November 10, 2018
- First published December 30, 2018.
Online issue publication
November 20, 2019
Article Versions
- Previous version (21 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Cardiac transthyretin amyloidosis
- The transthyretin amyloidoses: advances in therapy
- Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
- Amyloid in the cardiovascular system: a review
- A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK
- Amyloidosis
- Amyloid diseases of the heart: assessment, diagnosis, and referral
- Diagnosis and management of sensory polyneuropathy
- Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy
- A rare cause of weakness